Similar articles for PMID: 19541812

Year	Number of Results
1988	1
1994	1
1995	1
1996	1
1997	2
1998	2
2000	1
2001	2
2002	5
2003	4
2004	2
2005	1
2006	6
2007	2
2008	6
2009	8
2010	10
2011	15
2012	7
2013	10
2014	10
2015	9
2016	8
2017	5
2018	8
2019	2
2020	3
2021	0

1

Intradialytic administration of daptomycin in end stage renal disease patients on hemodialysis.

Salama NN, Segal JH, Churchwell MD, Patel JH, Gao L, Heung M, Mueller BA. Salama NN, et al. Clin J Am Soc Nephrol. 2009 Jul;4(7):1190-4. doi: 10.2215/CJN.01650309. Epub 2009 Jun 18. Clin J Am Soc Nephrol. 2009. PMID: 19541812 Free PMC article. Clinical Trial.

2

Single-dose daptomycin pharmacokinetics in chronic haemodialysis patients.

Salama NN, Segal JH, Churchwell MD, Patel JH, Gao L, Heung M, Mueller BA. Salama NN, et al. Nephrol Dial Transplant. 2010 Apr;25(4):1279-84. doi: 10.1093/ndt/gfp655. Epub 2009 Dec 10. Nephrol Dial Transplant. 2010. PMID: 20007981 Free PMC article.

3

Daptomycin dosing strategies in patients receiving thrice-weekly intermittent hemodialysis.

Haselden M, Leach M, Bohm N. Haselden M, et al. Ann Pharmacother. 2013 Oct;47(10):1342-7. doi: 10.1177/1060028013503110. Ann Pharmacother. 2013. PMID: 24259698 Review.

4

Pharmacokinetics and safety of multiple doses of daptomycin 6 mg/kg in noninfected adults undergoing hemodialysis or continuous ambulatory peritoneal dialysis.

Benziger DP, Pertel PE, Donovan J, Yankelev S, Schwab RJ, Swan SK, Cannon C. Benziger DP, et al. Clin Nephrol. 2011 Jan;75(1):63-9. Clin Nephrol. 2011. PMID: 21176752 Clinical Trial.

5

Pharmacokinetics and pharmacodynamics of intravenous daptomycin during continuous ambulatory peritoneal dialysis.

Cardone KE, Lodise TP, Patel N, Hoy CD, Meola S, Manley HJ, Drusano GL, Grabe DW. Cardone KE, et al. Clin J Am Soc Nephrol. 2011 May;6(5):1081-8. doi: 10.2215/CJN.08510910. Epub 2011 Mar 10. Clin J Am Soc Nephrol. 2011. PMID: 21393490 Free PMC article. Clinical Trial.

6

Comparison of 3 vancomycin dosage regimens during hemodialysis with cellulose triacetate dialyzers: post-dialysis versus intradialytic administration.

Mason NA, Neudeck BL, Welage LS, Patel JA, Swartz RD. Mason NA, et al. Clin Nephrol. 2003 Aug;60(2):96-104. doi: 10.5414/cnp60096. Clin Nephrol. 2003. PMID: 12940611 Clinical Trial.

7

Use of pharmacokinetic and pharmacodynamic principles to determine optimal administration of daptomycin in patients receiving standardized thrice-weekly hemodialysis.

Patel N, Cardone K, Grabe DW, Meola S, Hoy C, Manley H, Drusano GL, Lodise TP. Patel N, et al. Antimicrob Agents Chemother. 2011 Apr;55(4):1677-83. doi: 10.1128/AAC.01224-10. Epub 2011 Jan 31. Antimicrob Agents Chemother. 2011. PMID: 21282429 Free PMC article.

8

Daptomycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis.

Vilay AM, Grio M, Depestel DD, Sowinski KM, Gao L, Heung M, Salama NN, Mueller BA. Vilay AM, et al. Crit Care Med. 2011 Jan;39(1):19-25. doi: 10.1097/CCM.0b013e3181fa36fb. Crit Care Med. 2011. PMID: 20890189

9

Vancomycin pharmacokinetics and pharmacodynamics during short daily hemodialysis.

Decker BS, Kays MB, Chambers M, Kraus MA, Moe SM, Sowinski KM. Decker BS, et al. Clin J Am Soc Nephrol. 2010 Nov;5(11):1981-7. doi: 10.2215/CJN.03450410. Epub 2010 Jul 8. Clin J Am Soc Nephrol. 2010. PMID: 20616157 Free PMC article. Clinical Trial.

10

Daptomycin pharmacokinetics and pharmacodynamics in a pooled sample of patients receiving thrice-weekly hemodialysis.

Butterfield JM, Mueller BA, Patel N, Cardone KE, Grabe DW, Salama NN, Lodise TP. Butterfield JM, et al. Antimicrob Agents Chemother. 2013 Feb;57(2):864-72. doi: 10.1128/AAC.02000-12. Epub 2012 Dec 3. Antimicrob Agents Chemother. 2013. PMID: 23208714 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed